Naval Daver, MD, University of Texas MD Anderson Cancer Center, shares recent work on combination magrolimab, a CD47-targeting monoclonal antibody, and the hypomethylating agent azacitidine. The azacitidine and…
Dileep R. Yavagal, MD, Professor of Neurology & Neurosurgery and Chief Interventional Neurologist at the University of Miami – Miller School of Medicine, describes a treatment that has…
This week, CBS News reported that Moderna's early data from their vaccine trials show 94.5% efficacy, with 5 vaccine recipients included in the trial's 95 confirmed cases, and…
Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Researchers from UC Davis Comprehensive Cancer Center discuss results from their recent study on long term complications adolescents and young adults face after treatment for acute myeloid leukemia…
Alessia Cavazza, PhD, of Great Ormond Street Institute of Child Health (ICH) at University College London, discusses her research related to the potential of emerging gene-editing technologies, particularly…
Courtney DiNardo, MD, MSCE, clinical researcher in the Department of Leukemia of the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center, presents promising…
Researchers at University of Missouri School of Medicine, led by James Cook, DVM, PhD, OTSC, have developed a test which screens for certain biomarkers they have identified as…
Hui-Zi Chen, MD, PhD, assistant professor in the Department of Internal Medicine, Division of Medical Oncology at the Ohio State University Comprehensive Cancer Center – James, discusses the…
Naval G. Daver, MD, associate professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center, explains the results of a phase 1 trial…
